Literature DB >> 3571855

A case of association between type I hyperlipoproteinemia and systemic lupus erythematosus (SLE). Effects of steroid treatment.

P Pauciullo, B De Simone, P Rubba, M Mancini.   

Abstract

The case of a girl aged 19 yr with hypertriglyceridemia and systemic lupus erythematosus (SLE) is described. The girl had been admitted to a Lipid Outpatient Clinic in 1981 and diagnosed as having a Type I hyperlipidemia pattern. In November 1984 the patient acutely developed a SLE syndrome. Steroid treatment led to a dramatic fall of serum triglycerides from a starting value of 2100 mg/dl to 95 mg/dl. The role of steroids in completely correcting genetically deficient Lipoprotein Lipase Activity (LLA) is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3571855     DOI: 10.1007/BF03346979

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  9 in total

1.  Acquired type I hyperlipoproteinemia with systemic lupus erythematosus, dysglobulinemia and heparin resistance.

Authors:  C J Glueck; R I Levy; H I Glueck; H R Gralnick; H Greten; D S Fredrickson
Journal:  Am J Med       Date:  1969-08       Impact factor: 4.965

2.  Quantitative determination of heparin released lipoprotein lipase activity in human plasma.

Authors:  J Boberg
Journal:  Lipids       Date:  1970-05       Impact factor: 1.880

3.  Lipolytic activities in post-heparin plasma in man measured with different substrate emulsions.

Authors:  B Vessby; J Boberg; H Lithell
Journal:  Clin Sci Mol Med       Date:  1978-02

4.  Quantitation of human serum very low density apolipoproteins C-I, C-II, C-III and E by enzyme immunoassay.

Authors:  L Holmquist
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

5.  Acquired type 3 hyperlipoproteinemia. Report of three cases associated with systemic lupus erythematosus and diabetic ketoacidosis.

Authors:  M P Stern; O G Kolterman; H McDevitt; G M Reaven
Journal:  Arch Intern Med       Date:  1972-12

6.  Effects of clofibrate treatment on plasma triglyceride concentration, plasma post-heparin clearing factor lipase (lipoprotein lipase) activity and serum clearing factor lipase activating ability in maturity-onset diabetes.

Authors:  M P Rogers; D Barnett; D S Robinson
Journal:  Atherosclerosis       Date:  1976-09       Impact factor: 5.162

7.  Human adipose tissue in culture. VIII. Studies on the insulin-antagonistic effect of glucocorticoids.

Authors:  M Cigolini; U Smith
Journal:  Metabolism       Date:  1979-05       Impact factor: 8.694

8.  Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity.

Authors:  J D Brunzell; N E Miller; P Alaupovic; R J St Hilaire; C S Wang; D L Sarson; S R Bloom; B Lewis
Journal:  J Lipid Res       Date:  1983-01       Impact factor: 5.922

9.  Effects of insulin, glucocorticoids and adrenaline on the activity of rat adipose-tissue lipoprotein lipids.

Authors:  P Ashby; D S Robinson
Journal:  Biochem J       Date:  1980-04-15       Impact factor: 3.857

  9 in total
  1 in total

Review 1.  Aspects of mixed connective tissue disease: a review.

Authors:  T H Dent; V W Johnson
Journal:  J R Soc Med       Date:  1992-12       Impact factor: 18.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.